封面
市场调查报告书
商品编码
1479957

全球心臟瓣膜产业,预测到2028年

Global Heart Valves Industry Forecast to 2028

出版日期: | 出版商: Frost & Sullivan | 英文 95 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

投资创新技术创造成长机会

在本次分析中,Frost & Sullivan 涵盖了心臟瓣膜产业,包括主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣。它解决了市场规模、成长率、成长机会、策略要务、技术影响和行业开拓潜力等关键问题。

根据分析,由于经导管技术的日益采用,该行业正在获得关注。经导管主动脉瓣置换术(TAVR)在过去几年中取得了良好的成长,并且在预测期内可能会继续成长。

产业相关人员正在开发经导管二尖瓣和三尖瓣技术,以抓住下一阶段的成长机会。 Frost & Sullivan 认为,随着许多新技术的发展以及这些技术的临床证据和监管核准的增加,心臟瓣膜产业正处于曲折点。

目标区域为北美、欧洲、亚太地区、拉丁美洲和中东/非洲。由于存在许多大公司和新兴企业,北美是最大的市场。由于受瓣膜性心臟病影响的人数众多以及人们对瓣膜性心臟病技术的认识和可及性不断提高,该行业在亚太地区正在快速增长。

研究期间为2021-2028年,其中2023年为基准年,2024-2028年为预测期间。

目录

策略要务

  • 为什么成长如此困难?
  • The Strategic Imperative 8(TM)
  • 关键策略要务对心臟瓣膜产业的影响
  • 成长机会推动Growth Pipeline Engine(TM)

成长机会分析

  • 心臟瓣膜
  • 分析范围
  • 分割
  • 细分:产品范例
  • 主要竞争对手
  • 成长环境
  • 概述
  • 成长指标
  • 生长促进因子
  • 成长抑制因素
  • 预测假设
  • 收益预测
  • 收益预测(按细分市场)
  • 按地区分類的收益预测
  • 收益预测分析
  • 按地区分類的收益预测分析
  • 价格趋势和预测分析
  • 竞争环境
  • 收益占有率
  • 收益占有率分析
  • 企业规划:关键参与者
  • 公司分布图:新兴企业

心臟瓣膜疾病

  • 心臟瓣膜疾病
  • 环状成形术环概述
  • 心臟瓣膜装置
  • 年轻患者的 TAVR
  • 扩大 TAVR 的应用
  • 对三尖瓣和二尖瓣技术的需求
  • 欧洲概况
  • 亚太地区概览
  • 患者照护途径
  • 患者的活化增加了新的机会
  • 患者参与

科技趋势

  • 影响心臟瓣膜产业的技术
  • 人工智慧在心臟瓣膜疾病的应用
  • 心臟瓣膜产业的Start-Ups公司
  • 心臟瓣膜的临床研究

成长机会分析:二尖瓣

  • 成长指标
  • 收益预测
  • 收益预测(按细分市场)
  • 按地区分類的收益预测
  • 预测分析

成长机会分析:主动脉瓣

  • 成长指标
  • 收益预测
  • 收益预测(按细分市场)
  • 按地区分類的收益预测
  • 预测分析

成长机会分析:三尖瓣

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

增长机会分析:肺瓣膜

  • 成长指标
  • 收益预测
  • 按地区分類的收益预测
  • 预测分析

成长机会宇宙

  • 成长机会1:经导管二尖瓣和三尖瓣修復和置换
  • 增长机会2:经导管主动脉瓣置换术
  • 成长机会3:先进心臟瓣膜材料
  • 成长机会4:亚太地区未满足的需求

下一步

简介目录
Product Code: K9E5-54

Investments in Innovative Technologies Enable Growth Opportunities

In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry.

Our analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period.

Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. Frost & Sullivan finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies.

Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies.

The study period is 2021-2028, with 2023 as the base year and 2024-2028 as the forecast period.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Heart Valves Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Heart Valves
  • Scope of Analysis
  • Segmentation
  • Segmentation: Product Examples
  • Key Competitors
  • Growth Environment
  • Summary
  • Growth Metrics
  • Growth Drivers
  • Growth Restraints
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Segment
  • Revenue Forecast by Region
  • Revenue Forecast Analysis
  • Revenue Forecast Analysis by Region
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Revenue Share
  • Revenue Share Analysis
  • Company Mapping: Major Players
  • Company Mapping: Emerging Companies

Heart Valve Diseases

  • Heart Valve Diseases
  • Annuloplasty Rings Overview
  • Heart Valve Devices
  • TAVR in Young Patients
  • Expanding TAVR Applications
  • Demand for Tricuspid and Mitral Technologies
  • Europe Overview
  • Asia-Pacific Overview
  • Patient Care Pathway
  • Patient Activation Increases New Opportunities
  • Patient Engagement

Technology Trends

  • Technologies Affecting the Heart Valves Industry
  • AI in Heart Valve Diseases
  • Start-ups in the Heart Valves Industry
  • Heart Valves in Clinical Research

Growth Opportunity Analysis: Mitral Valves

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Segment
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Analysis: Aortic Valves

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Segment
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Analysis: Tricuspid Valves

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Analysis: Pulmonary Valves

  • Growth Metrics
  • Revenue Forecast
  • Revenue Forecast by Region
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1: Transcatheter Mitral and Tricuspid Valve Repair and Replacement
  • Growth Opportunity 2: Transcatheter Aortic Valve Replacement
  • Growth Opportunity 3: Advanced Heart Valve Materials
  • Growth Opportunity 4: Unmet Needs in Asia-Pacific

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer